Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Exonics Therapeutics
company
About
Exonics Therapeutics, a Boston, Mass.-based biotechnology company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $5M
- Industries
- Biopharma,Biotechnology,Medical Device,Therapeutics
- Founded date
- Nov 30, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Exonics’ laboratory has demonstrated the ability to use adeno-associated virus (AAV) to deliver a payload based on CRISPR/Cas9 technology that can identify and correct exon mutations that prevent the production of dystrophin, a protein that helps stabilize and protect muscle fibers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$5M
Exonics Therapeutics has raised a total of
$5M
in funding over 2 rounds. Their latest funding was raised on
Feb 27, 2017 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 27, 2017 | Seed | $5M | 1 |
CureDuchenne Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Exonics Therapeutics is funded by 1 investors.
CureDuchenne Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CureDuchenne Ventures
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
